Health & Medicine Theories

Claims circulate that pharmaceutical companies or medical institutions suppress Repatha (evolocumab, a PCSK9 inhibitor approved by the FDA in 2015) or effective alternatives to statins. The claim has no documentary basis. Repatha is FDA-approved, actively marketed by Amgen, and available by prescription in more than 60 countries. Its limited uptake relative to statins reflects cost, insurance coverage, and prescribing guidelines — not suppression. Statins remain the first-line standard of care because they are proven, inexpensive, and widely effective; PCSK9 inhibitors are used as second-line or add-on therapy for high-risk patients who cannot tolerate or do not respond adequately to statins.

In January 2022 a federal district court ordered the FDA to release Pfizer's COVID-19 vaccine clinical-trial documents at a pace far faster than the FDA had proposed (75 years vs the court-ordered monthly schedule). Social-media commentary framed the documents as proving concealed mass harm. In reality, the documents are routine pharmacovigilance data — adverse-event tables compiled because post-market safety surveillance is legally required. The "75 years to hide it" framing misrepresents standard FOIA processing timelines; the underlying documents are real and are publicly available.

Claims that seed oils are a hidden toxin and that detox products or strict elimination protocols cure broad disease categories.